TAK Cost of Revenue
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Cost of Revenue
TAK Cost of Revenue
Latest reported¥1.91T JPYperiod ending
TAK Cost of Revenue · JPY (¥432.33B → ¥1.91T)
Annual cost of revenue
High-resolution chart · PNG
TAK cost of revenue history
Annual fiscal periods · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (JPY) |
|---|---|
| 2,338,118,761,000 | |
| 1,580,217,000,000 | |
| 1,431,505,000,000 | |
| 1,244,072,000,000 | |
| 1,106,846,000,000 | |
| 994,308,000,000 | |
| 1,089,764,000,000 | |
| 659,690,000,000 | |
| 495,921,000,000 | |
| 558,755,000,000 | |
| 535,405,000,000 | |
| 520,990,000,000 | |
| 490,263,000,000 | |
| 447,628,000,000 | |
| 433,194,000,000 | |
| 317,582,000,000 | |
| 285,064,000,000 | |
| 289,543,000,000 | |
| 278,631,000,000 | |
| 279,662,000,000 | |
| 282,102,000,000 | |
| 279,179,000,000 | |
| 269,395,000,000 | |
| 300,344,000,000 | |
| 337,854,000,000 | |
| 384,013,000,000 | |
| 432,333,000,000 |